OBJECTIVES: To evaluate the temporal stability and responsiveness of the Montreal Cognitive Assessment (MoCA) in acquired @entity1545 (ABI). RESEARCH DESIGN AND METHODS: English-speaking adults with @entity64 or moderate-to-severe @entity131 were administered alternate forms of the MoCA (version 1, then 2), 6 weeks apart. Chronic group @entity1 (n   =   40) were community-dwelling, at least 1 year post-ABI (mean   =   12.1 years, SD   =   9.0), and presumed clinically stable. Sub-acute group @entity1 (n   =   36) were 30.8 days post-ABI (SD   =   12.4) and were undergoing intensive rehabilitation. Individuals with an unstable medical or @entity146 condition or severe receptive aphasia were not eligible. RESULTS: The chronic group scored 21.6 (SD   =   4.5) initially and 22.7 (SD   =   3.8) on the second administration, demonstrating a small but significant practise effect (p   =   0.009). The Pearson test-re-test correlation coefficient was 0.83. Using reliable change methodology in the chronic group, the 80% confidence interval (CI) for change across the two administrations was -2 to +4, adjusting for practise. Applied to the sub-acute group, 39% improved and 0% declined. CONCLUSIONS: The MoCA is a brief standardized tool that appears useful for monitoring @entity73 after ABI. The findings enable clinicians to detect statistically reliable change across serial MoCA administrations in individuals with an ABI.

Temporal stability and responsiveness of the Montreal Cognitive Assessment following acquired XXXX .

@entity1545 :: ('MESH:D020214', 'Disease') :: ['brain injury'] @entity1 :: ('9606', 'Species') :: ['participants'] @entity131 :: ('MESH:D001930', 'Disease') :: ['traumatic brain injury'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke'] @entity146 :: ('MESH:D001523', 'Disease') :: ['psychiatric'] @entity73 :: ('MESH:D003072', 'Disease') :: ['cognitive change']
@entity1545 :: (MESH:D020214,Disease) :: ['brain injury']
